Prot #SGNBB228‐001: A Phase 1 Study of SGN‐BB228 in Advanced Melanoma and Other Solid Tumors

Project: Research project

Project Details

StatusActive
Effective start/end date7/11/237/11/26

Funding

  • Seattle Genetics, Inc. (Prot #SGNBB228-001)